SCHEMBL70387

SCHEMBL70387

CC1(C)c2cc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)ccc2-c2ccc(-c3ccc(B4OC(C)(C)C(C)(C)O4)cc3)cc21

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 13/20 0.59
LPL P06858 12/20 0.59
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
F11 P03951 1/20 0.39
SNCA P37840 1/20 0.39
ESR2 Q92731 1/20 0.36
DGAT1 O75907 1/20 0.36
P4HB P07237 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12781865 0.97 LIPG (0.56) LIPGLPLCA1CA2CA9
SCHEMBL1753517 0.93 LIPG (0.50) LIPGLPLCA1CA2CA9
SCHEMBL1753909 0.93 LIPG (0.59) LIPGLPLCA1CA2CA9
SCHEMBL429991 0.90 LIPG (0.64) LIPGLPLCA1CA2CA9
SCHEMBL15763801 0.88 LIPG (0.54) LIPGLPLCA1CA2CA9
SCHEMBL19770123 0.88 LIPG (0.47) LIPGLPLCA1CA2CA9
SCHEMBL29981405 0.88 LIPG (0.47) LIPGLPLCA1CA2CA9
SCHEMBL19612784 0.87 LIPG (0.46) LIPGLPLCA1CA2CA9
SCHEMBL430244 0.86 LIPG (0.51) LIPGLPLCA1CA2CA9
SCHEMBL431646 0.86 LIPG (0.51) LIPGLPLCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11943997-B2 Polymer, composition for organic electroluminescent element, organic electroluminescent element, organic EL display device, organic EL lighting, and manufacturing method for organic electroluminescent element MITSUBISHI CHEMICAL CORPORATION (JP) 2024-03-26 US disclosed
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20110054229-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2011-03-03 US disclosed
US-20110054229-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME GRACEL DISPLAY INC. (KR) 2011-03-03 US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 LIPG 2246/4885LPL 2008/4885CA1 2225/4885
US-20110054229-A1 LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD2, OCIAD1, ORMDL3 LIPG 2045/4885LPL 1138/4885CA1 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.